Loading
Latest filing published 19 Jun 2016 for Zenith Epigenetics Corp., €3,120.
No signal scores available.
All filings by Eldon Smith on record concern Zenith Epigenetics Corp. In total, 2 filings cover trades dated from 29 April 2016 to 14 June 2016.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 19 June 2016: an option exercise of €3,120, in Zenith Epigenetics Corp. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations